R&D Partner Content 8th Neuropsychiatric Drug Development Summit The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum, capturing advancements across discovery...
R&D Partner Content 7th TRP Europe | November 2025, Amsterdam | Agenda Released With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, real momentum is building in the field.
R&D Partner Content 16th World ADC San Diego 2025 The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
R&D Partner Content 15th World Clinical Biomarkers & Companion Diagnostics Summi... The biomarkers and diagnostics field continues to boom, driven by advancements in genomic profiling, omics, and AI technologies.
R&D Partner Content 5th iPSC Drug Development Summit Advance iPSC therapies from bench to bedside with 30+ industry experts at this year’s summit.
R&D Partner Content Register Now for AAPS PharmSci 360! Learn from pharmaceutical scientists involved at every stage of the drug development pipeline at PharmSci 360.
News Major trial launched to explore GLP-1 benefit in dementia A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.